Evaluation of a carbapenem-saving strategy using empirical combination regimen of piperacillin-tazobactam and amikacin in hemato-oncology patients

Journal of Korean Medical Science

Volumn 34, Issue 2, 2019, Pages

  Ko, Jae Hoon ^a,b   Kim, Si Ho ^a   Kang, Cheol In ^a   Cho, Sun Young ^a   Lee, Nam Yong ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Song, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Armed Forces Capital Hospital   (South Korea)

Author keywords

Amikacin; Carbapenem saving; Gram negative Bacilli; Piperacillin tazobactam; Resistance

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENTEROBACTERIACEAE; FEBRILE NEUTROPENIA; HUMAN; MICROBIOLOGY; PATHOLOGY; PHARMACOLOGY;

AMIKACIN; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FEBRILE NEUTROPENIA; HUMANS; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION;

EID: 85059914635     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2019.34.e17     Document Type: Article

References (11)

1. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62(10):e51-77
2. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52(4):e56-93
3. Cha MK, Kang CI, Kim SH, Cho SY, Ha YE, Wi YM, et al. In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia. Antimicrob Agents Chemother 2015;59(9):5834-7
4. Park GE, Ko JH, Peck KR, Lee JY, Lee JY, Cho SY, et al. Control of an outbreak of middle east respiratory syndrome in a tertiary hospital in Korea. Ann Intern Med 2016;165(2):87-93
5. Huh K, Chung DR, Park HJ, Kim MJ, Lee NY, Ha YE, et al. Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance. Am J Infect Control 2016;44(9):e145-52
6. Chang YT, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, et al. Epidemiology and trends in the antibiotic susceptibilities of gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013. Int J Antimicrob Agents 2017;49(6):734-9
7. Park JJ, Seo YB, Lee J. Antimicrobial susceptibilities of Enterobacteriaceae in community-acquired urinary tract infections during a 5-year period: a single hospital study in Korea. Infect Chemother 2017;49(3):184-93
8. Kim HS, Park BK, Kim SK, Han SB, Lee JW, Lee DG, et al. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study. BMC Infect Dis 2017;17(1):500
9. Morgan DJ, Liang SY, Smith CL, Johnson JK, Harris AD, Furuno JP, et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 2010;31(7):716-21
10. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006;64(1):7-15
11. Choi WS, Kim SH, Jeon EG, Son MH, Yoon YK, Kim JY, et al. Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program. J Korean Med Sci 2010;25(7):999-1004